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after transplantation, may then increase diastolic dysfunc-
tion, thus enhancing BNP secretion in heart transplanta-
tion.
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CARDIOPULMONARY BYPASS–INDUCED INCREASE OF SERUM INTERLEUKIN-10 LEVELS IN
CHILDREN
Attila Ta´rnok, PhD, Jo¨rg Hambsch, MD, and Peter Schneider, MD, Leipzig, Germany
During pediatric cardiac operations with cardiopulmo-
nary bypass (CPB), the serum levels of various inflamma-
tory cytokines change dramatically.1 Recent studies in
children demonstrate that interleukin-10 (IL-10), a cyto-
kine that acts in an immunosuppressive manner, is liber-
ated during2 or after3 pediatric cardiac operations. The
information provided by these authors, however, are
conflicting with respect to the amplitude and the kinetics
of secreted IL-10.2, 3 Seghaye and colleagues2 reported
two peaks of IL-10 release, one during and a second after
CPB, with maximums at the end of CPB and 1 day after
the operation, respectively. Data from Sugita and associ-
ates3 indicate earlier IL-10 release, with maximums during
reperfusion and a few hours after the operation. Their
data are similar to data reported for adults4 with respect
to the kinetics of IL-10 release. In contrast, Sugita and
associates3 reported initial and peak IL-10 values that
were more than 10 times as high as in adults4 and in
infants until 10 months after birth.2 We analyzed the
kinetics of IL-10, interleukin-6 (IL-6) and tumor necrosis
factor–a (TNF-a) release in children undergoing cardiac
operations to clarify the release pattern of IL-10 in
children.
Patients and methods. After informed consent was
obtained, 24 children with atrial septal defects (atrial
septal defect I, n 5 1; atrial septal defect II, n 5 13) or
ventricular septal defects (n 5 10) undergoing cardiac
operations were analyzed. The surgical procedures were
ventricular septal defect closure and atrial septal defect
repair, respectively. General anesthesia and myoplegia
were performed with midazolam, fentanyl, and pancuro-
nium. CPB was performed with a roller pump (Sto¨ckert
Instrumente GmbH, Munich, Germany) and hollow-fiber
oxygenator (DIDECO, Mirandola, Italy). The priming
solution consisted of a crystalloid solution, mannitol (3
ml/kg body weight), and Iono-lactat (Fresenius, Bad
Homburg, Germany). In a few cases, priming was com-
pleted with compatible erythrocyte concentrate. During
CPB, the hematocrit level was kept at 22% to 30% and the
flow rate was maintained at 2.7 to 3.5 L/m2/min. Hypo-
thermia was induced by cooling priming solution and
circulating blood with the heat exchanger. During the
cooling period, all patients received sodium nitroprusside
(0.3 to 2.0 mg/kg/min) for vasodilatation. Bretschneider’s
cardioplegic solution was used for myocardial perfusion.
Our perioperative antibiotic regimen consisted of cefazo-
lin (50 mg/kg body weight) in three separate doses. During
rewarming, heated and humidified inspired gases were
used and sodium nitroprusside was administered intrave-
nously. At the end of CPB, all but one patient underwent
hemofiltration, normal flow was reestablished, and the
patients were rewarmed. The lungs were reventilated and
heparin was neutralized with protamine sulfate. In all but
two cases, a catecholamine (dobutamine or dopamine at 2
to 6 mg/kg/min) was infused before the patients were
weaned from bypass. No corticosteroids were applied
before, during, or after the operation.
Blood samples were collected 1 day before the opera-
tion (–1d); after the onset of anesthesia (anesthesia); 10
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minutes after onset of CPB; before the end of the CPB
during rewarming (CPB end); 4 to 6 hours after the
operation and protamine administration (14h); 1, 2, and
3 days after the operation (11d, 12d, and 13d); and
shortly before discharge (discharged). Blood was collected
in untreated tubes (IL-10 and IL-6) or tubes treated with
ethylenediaminetetraacetic acid (EDTA; TNF-a), and
serum or EDTA-treated plasma samples were stored
within 30 to 40 minutes after sampling at –80° C until
analysis. Cytokine concentrations were determined by
enzyme-linked immunoabsorbent assay. The detection
ranges were 16 to 2000 pg/ml for IL-10 assay (sensitivity
1.5 pg/ml; Boehringer Ingelheim, Ingelheim, Germany),
3.13 to 300 pg/ml for IL-6 (sensitivity 0.7 pg/ml, Quan-
tikine; R&D Systems, Minneapolis, Minn.), and 15.6 to
1000 pg/ml for TNF-a (sensitivity 5 pg/ml; Immunotech,
Hamburg, Germany). Data obtained during CPB were not
corrected for hemodilution. Statistical analysis was done
with paired two-tailed Student’s t tests.
Results. Patients and surgical data are shown in Table
I. The surgical and clinical outcomes were good for all
children. Twelve of the children had minor postoperative
complications such as pericardial effusion, edema, and
liver swelling. Fig. 1 shows the kinetics of the analyzed
serum parameters. Mean IL-10 level before the operation
was 2.3 6 3.6 pg/ml (mean 6 standard deviation; range 0.0
to 14.6 pg/ml). IL-10 concentration rose, with highest
values during reperfusion (50.0 6 71.6 pg/ml, p 50.003),
remained elevated as long as 4 hours after the operation
(p 5 0.04), and was at baseline later on. The basal TNF-a
level was 16.9 6 17.6 pg/ml (range 0.0 to 61.9 pg/ml); it
decreased significantly during CPB (p 5 0.004 at 10
minutes of CPB), returned to basal levels 1 day after the
operation, and was not significantly increased after the
operation. Il-6 levels were initially low (1.0 6 1.8 pg/ml;
range 0.0 to 7.2 pg/ml). IL-6 increased during reperfusion
(p 5 0.003), with a maximum 4 hours after the operation
(p 5 0.00005), and remained elevated after the operation
(p 5 0.02). There were no clear differences in the release
patterns of IL-10, IL-6, and TNF-a between children with
and without catecholamine administration. Linear regres-
sion analysis demonstrated no correlation of peak IL-10
levels with minimal rectal temperature during bypass and
preoperative, intraoperative, or postoperative TNF-a lev-
els (r2 , 0.02). In contrast, peak IL-10 levels at reperfu-
sion were slightly positively correlated with IL-6 levels
determined at the same time (r2 5 0.35).
Discussion. The kinetics of IL-10 secretion we saw
during pediatric cardiac operations are in apparent con-
Fig. 1. Alterations of serum concentrations of IL-10, IL-6, and TNF-a in children undergoing heart
operations with CPB. Data display mean values of 24 children. Error bars indicate standard error of the
mean. Asterisks indicate values significantly different from basal values (p , 0.05).




Age (yr) 7.42 6 1.98 5.08-11.08
Weight (kg) 24.57 6 7.98 12.5-39.5
Surgical duration (min) 173.6 6 57.7 60-280
CPB duration (min) 57.6 6 33.9 23-109
AXT duration (min) 30.3 6 25.3 12-76
Minimal rectal
temperature (°C)
31.9 6 3.6 23.0-36.2
Hemofiltration volume
(ml)
460 6 386 150-1,200
(patient without filtration)
AXT, Aortic crossclamping.
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flict with data recently published by Seghaye and col-
leagues.2 They are similar to data presented by Sugita and
associates3 for children and by Tabardel and coworkers4
for adults. Whereas Sugita and associates3 and we found
an immediate increase in IL-10 levels after the operation
and normal levels 1 day later, Seghaye and colleagues2
reported a second, more pronounced peak 1 day after the
operation. The first peak in the study of Seghaye and
colleagues2 is similar in amplitude to our findings but a
tenth that reported by Sugita and coworkers.3 Our preop-
erative serum levels of IL-10 and TNF-a are in agreement
with data reported for infants2 and adults.4
In contrast to the study of Seghaye and colleagues,2
there were no increased TNF-a levels during CPB. This
difference between the studies potentially arises from two
different mechanisms underlying the IL-10 secretion. As
previously shown,5 there are two major producers of IL-10
in human beings, monocytes and T lymphocytes. Acti-
vated monocytes secrete IL-10 after stimulation with
TNF-a, whereas IL-10 secretion from activated T cells is
triggered by interleukin-12, IL-6, or both. In our study,
IL-10 levels did not correlate with TNF-a levels before or
during the operation. In contrast, Il-6 levels correlated
slightly with IL-10 levels during reperfusion. From these
data, we conclude that T cells were probably the major
source of IL-10 in our patients. This hypothesis is sup-
ported by our recent finding that monocyte activity (e.g.,
class II major histocompatibility complex expression) is
regulated downward immediately after the start of the
surgical procedure.1 Similar results were reported by
Habermehl (Habermehl P, University of Mainz, Ger-
many; unpublished observations). During CPB, the phe-
notype of T lymphocytes changes into “naive” (CD45RA
expressing) T lymphocytes.1 “Naive” T lymphocytes tend
to develop into helper-2 T lymphocytes and secrete IL-10,
among other factors, on appropriate stimulation.6 A sim-
ilar response could have occurred in the patient group
analyzed by us, that analyzed by Sugita and associates,3
and in adults.4 In the study of Seghaye and colleagues,2 on
the other hand, mainly activated monocytes could have
contributed to the postoperative IL-10 secretion.
Comparison of anesthesia, medication, and surgical and
postoperative protocols did not show major discrepancies
between the study of Seghaye and colleagues2 and our
study that could explain the measured differences. Al-
though the mean durations of the surgical procedures,
CPB, and aortic crossclamping were lower and the mini-
mal temperature was higher than in the study of Seghaye
and colleagues,2 these values had a broadly overlapping
distribution in the two studies. In our study, even in
patients with the longest procedures, CPB, and cross-
clamp time, no second IL-10 peak was detectable. The
patient data suggest, however, that the ages of the chil-
dren may play a crucial role in the release kinetics of IL-10
and the type of cells involved. In the study of Seghaye and
colleagues,2 infants 2 to 10 months old were analyzed. In
our study and that of Sugita and associates,3 the children
were older. This difference could indicate that the mech-
anism of IL-10 induction by CPB in patients with congen-
ital heart disease is age dependent and develops from a
mostly monocyte-dependent to a T cell–specific response.
This could explain why IL-10 release during cardiac
operations in adults4 follows mostly the kinetics we found.
In addition, age-related differences in surgical procedure,
other type of extracorporeal circuit, non–whole-blood
priming, and hemofiltration may have altered the immune
response. In an extended study, we have started to analyze
the release pattern of cytokines during cardiac operations
in infants and perform in vitro studies to scrutinize the
source of IL-10. We believe that a clarification of the age
dependency of the immune response could finally lead to
more age-specific therapy.
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